Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist for Chronic Weight Management and Type 2 Diabetes
Free
Log In
Overview
This Activity for
- Pharmacy
- Clinical Pharmacy
What I will learn?
•Understand the mechanism of action of Mounjaro, a once-weekly, first-in-class GIP and GLP-1 receptor agonist for chronic weight management and type 2 diabetes.
•Review the efficacy and safety of Mounjaro in chronic weight management and type 2 diabetes.
•Review the efficacy superiority of Tirzepatide compared with Semaglutide in chronic weight management.
•Discuss the safe and effective use of Mounjaro.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist for Chronic Weight Management and Type 2 Diabetes Certificate | Certificate | Free |
VAT 15% Included